Navigation Links
Christopher and Dana Reeve Foundation Response to FDA Clearance of Geron's Clinical Trial
Date:1/23/2009

SHORT HILLS, N.J., Jan. 23 /PRNewswire-USNewswire/ -- Peter T. Wilderotter, president and CEO of the Christopher & Dana Reeve Foundation, issued the following statement today in response to FDA clearance of Geron's human clinical trial of embryonic stem cell-based therapy:

"This is an exciting first step for Geron and for spinal cord injured patients whose lives may improve due to advances in medical research. There has been so much speculative and unsubstantiated information about the use of stem cells in spinal cord injury; it is important to study these cells in a rigorously designed clinical trial that is monitored by the FDA."

Wilderotter continued, "Christopher and Dana Reeve brought national attention to this issue and they gave voice to all those who are suffering the devastating physical, emotional and financial impact of challenging neurological conditions. Their belief in the promise of stem cell research became a part of their lasting legacy."

Shortly before his death, Christopher Reeve wrote, "It is our responsibility to do everything possible to protect the quality of life of the present and future generations...No obstacle should stand in the way of responsible investigation of their [stem cells] possibilities."

Wilderotter concluded, "This is the dawn of basic research being translated into human clinical trials for people living with spinal cord injury. We are hopeful that what is learned from the results will enable us to move forward with therapies for people living with spinal cord injuries."

About the Reeve Foundation

The Christopher and Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, information and advocacy. For more information, and to review the entire list of Quality of Life grant recipients, please visit our website at www.ChristopherReeve.org or call 800-225-0292.


'/>"/>
SOURCE The Christopher and Dana Reeve Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ameristar National Charity Golf Classic Raises More Than $1.1 Million for Buoniconti Fund to Cure Paralysis and Christopher & Dana Reeve Foundation
2. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
3. Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
4. Quintiles Appoints Christopher Cabell to Chief Medical and Scientific Officer
5. Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
8. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
9. Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market
10. HEALTHeCAREERS Network Pledges $15,000 to ASRT Foundation for Professional Healthcare Training
11. Stem Cell Sciences Enters into Services Agreement with Huntingdons Disease Research Group, CHDI Foundation Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed for ... complexity. Named in honor of pioneering researcher Rosalind Franklin, who made a ...
(Date:10/11/2017)... ... ... is a basic first aid supply for any work environment, but most personal eye wash ... if a dangerous substance enters both eyes? It’s one less decision, and likely quicker response ... piece. , “Whether its dirt and debris, or an acid or alkali, getting anything in ...
(Date:10/11/2017)... INDIANAPOLIS , Oct. 11, 2017  VMS BioMarketing, a ... of a nationwide oncology Clinical Nurse Educator (CNE) network, which ... growing need for communication among health care professionals to enhance ... physicians, nurses, office staff, and other health care professionals to ... for breast cancer. ...
(Date:10/11/2017)... TX (PRWEB) , ... October 11, 2017 , ... ... August compared the implantation and pregnancy rates in frozen and fresh in ... contribution of progesterone and maternal age to IVF success. , After comparing the ...
Breaking Biology Technology:
(Date:7/20/2017)... , July 20, 2017 Delta (NYSE: DAL ... board any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to ... Delta,s biometric ... Sky Club is now integrated into the boarding process to allow ...
(Date:6/14/2017)... PARIS , June 15, 2017  IBM (NYSE: IBM ... the international tech event dedicated to developing collaboration between startups ... on June 15-17. During the event, nine startups will ... deliver value in various industries. ... in the international market, with a 30 percent increase in ...
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
Breaking Biology News(10 mins):